AK
Azhar Khan
About Azhar Khan
Data last updated:
Azhar Khan has 2 years in corporate governance. Holds Director role. Currently with 2 companies, including Oryzian Proteins Private Limited and Primevita Lifescience Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Oryzian Proteins Private Limited at ₹10.79 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Oryzian Proteins Private Limited U51909DL2022PTC394392 | Director | 14 Oct 2024 | 2022 | ₹10.79 Cr (FY 2025) | Active |
| Primevita Lifescience Private Limited U46204GJ2024PTC155416 | Director | 28 Sep 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Azhar Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Azhar Khan
Azhar Khan has 2 years in corporate governance. Holds Director role. Currently with 2 companies, including Oryzian Proteins Private Limited and Primevita Lifescience Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Oryzian Proteins Private Limited at ₹10.79 Cr (FY 2025).
Azhar Khan is associated with 2 companies as Director, including Oryzian Proteins Private Limited (₹10.79 Cr), Primevita Lifescience Private Limited.
Azhar Khan has expertise in General Business.
Azhar Khan has 2 years in corporate governance.
By reported revenue, the largest current company of Azhar Khan is Oryzian Proteins Private Limited, with revenue of ₹10.79 Cr (FY 2025).
Azhar Khan currently holds positions at 2 companies: Oryzian Proteins Private Limited (₹10.79 Cr), Primevita Lifescience Private Limited.